Work

Engineering Resistance to CD33-Targeted Immunotherapy in Normal Hematopoiesis By CRISPR/Cas9-Deletion of CD33 Exon 2

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-117856

Authors: Roland B. Walter, Olivier Humbert, George S. Laszlo, Sophie R. Sichel, Christina M. Ironside, Kevin G. Haworth, Olivia M. Bates, Mary E. Beddoe, Ray R. Carillo, Hans-Peter Kiem

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2912816336

Cites:

Cited by: 1

Related to: 10